🔎 Trials Near Me

Pradžia › Vilkligės nefritas › Masčusetsas

Vilkligės nefritas klinikiniai tyrimai Masčusetsas

8 tyrimai dėl Vilkligės nefritas ieško dalyvių vietose Masčusetsas.

Miestai Masčusetsas

Oficialus tyrimo tekstas (anglų kalba)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Brigham and Womens Hosp Harvard Med School, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-10-01 · NCT05268289

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, Boston
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-10 · NCT06897930

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • Boston Medical Center, Boston
Renkami dalyviai1 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-28 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
  • ir dar 2
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-08-26 · NCT06121297

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-14 · NCT07115745

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

  • Nkarta Investigational Site, Worcester
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-04 · NCT06557265

Dapagliflozin in Active Lupus Nephritis

  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-05-26 · NCT07323524

Lupus Landmark Study: A Prospective Registry and Biorepository

  • Brigham and Women's Hospital, Boston
  • University of Massachusetts Memorial Health, Worcester
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 110 · Visoms lytims · Atnaujinta 2026-04-15 · NCT05934149

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.